People: DexCom Inc (DXCM.O)
DXCM.O on Nasdaq
22.80USD
18 Jun 2013
22.80USD
18 Jun 2013
Price Change (% chg)
$0.24 (+1.06%)
$0.24 (+1.06%)
Prev Close
$22.56
$22.56
Open
$22.66
$22.66
Day's High
$22.97
$22.97
Day's Low
$22.47
$22.47
Volume
373,066
373,066
Avg. Vol
513,806
513,806
52-wk High
$22.97
$22.97
52-wk Low
$10.65
$10.65
Skyler, Jay
Brief Biography
Dr. Jay S. Skyler, M.D, MACP, is an Independent Director of DexCom Inc., since September 2002. Dr. Skyler is a Professor of Medicine, Pediatrics and Psychology and Deputy Director of the Diabetes Research Institute at the University of Miami in Florida, where he has been employed since 1976. Dr. Skyler also serves as Study Chairman for the National Institute of Diabetes & Digestive & Kidney Diseases Type 1 Diabetes TrialNet clinical trials network. Dr. Skyler also serves as a director of Amylin Pharmaceuticals, Inc., and served as a director of MiniMed, Inc. until its acquisition by Medtronic, Inc. in 2001. Dr. Skyler received a B.S. from Pennsylvania State University and an M.D. from Jefferson Medical College.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Jonathan Lord |
-- |
Kevin Sayer |
2,046,680 |
Terrance Gregg |
3,486,410 |
Jess Roper |
664,714 |
Steven Pacelli |
1,971,840 |
Andrew Balo |
913,314 |
As Of 30 Dec 2011

